Edition:
United States

Nitto Denko Corp (6988.T)

6988.T on Tokyo Stock Exchange

8,784JPY
20 Jan 2017
Change (% chg)

-- (--)
Prev Close
¥8,784
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
1,023,241
52-wk High
¥9,197
52-wk Low
¥5,175

Select another date:

Thu, Nov 10 2016

Bristol-Myers' deepens focus on fibrosis with Nitto deal

Bristol-Myers Squibb Co said on Thursday it agreed to pay Japan's Nitto Denko Corp $100 million up front for the right to its early-stage drug for liver fibrosis due to fatty liver disease NASH or hepatitis C.

Bristol-Myers' deepens focus on fibrosis with Nitto deal

Nov 10 Bristol-Myers Squibb Co said on Thursday it agreed to pay Japan's Nitto Denko Corp $100 million up front for the right to its early-stage drug for liver fibrosis due to fatty liver disease NASH or hepatitis C.

BRIEF-Nitto Denko acquires two U.S. Biomedical companies - nikkei

* Nitto Denko has acquired two U.S. Biomedical companies so it can handle all drug production steps on its own - nikkei

BRIEF-Future says lawsuit filed by NITTO DENKO

* Says NITTO DENKO CORPORATION filed lawsuit to against the judgment disclosed on June 17 regarding the co and the co's unit

Select another date: